過剰なセロトニン自己抑制と関連した不規則な自律的調節障害と死亡
Enrica Audero1, Elisabetta Coppi, Boris Mlinar
1Mouse Biology Unit, European Molecular Biology Laboratory (EMBL), Via Ramarini 32, 00015 Monterotondo, Italy.
まとめ
ネズミのセロトニン自己受容体を変えることで,自律的調節が妨げられ,突然の死が引き起こされた. この研究は,セロトニンの不均衡を突然の乳児死亡症候群と結びつける潜在的なメカニズムを明らかにしています.
科学分野:
- 神経科学は神経科学である.
- 発達生物学 発達生物学について
- 生理学 生理学とは
背景:
- 突然の乳児死亡症候群 (SIDS) は,新生児死亡率の主な原因です.
- 脳幹のセロトニンニューロン変異は,SIDSの症例で観察されています.
- セロトニンホメオスタシスをSIDSと結びつける正確なメカニズムは不明である.
研究 の 目的:
- 変化したセロトニンニューロン自己抑制の機能的影響を調査する.
- 自律的調節と生存におけるセロトニン1A自己受容体の役割を調査する.
主な方法:
- セロトニン1A自己受容体の可逆的な過剰発現を有するトランスジェニックマウスを利用した.
- 心拍数や体温を含む生理学的パラメータをモニタリングする.
- 環境課題に対する自律的な対応を評価した.
主要な成果:
- 過剰発現したマウスは,特定の発達ウィンドウで散発的なブラジカルディアと低体温症を示した.
- これらの自律的調節障害は,しばしば死亡まで進行した.
- マウスは,挑戦されたときに自律的標的器官の活性化が低下したことを示した.
結論:
- 過剰なセロトニン自己抑制は,重度の自律失調の危険因子として作用する.
- SIDSにおけるセロトニンホメオスタシスの変化に関与する潜在的なメカニズムを提供します.
- 突然死を予防するセロトニンニューロン調節の重要な役割を強調しています.
関連する概念動画
Disorders of the Autonomic Nervous System
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's phenomenon, is a...
Raynaud's disease, also known as Raynaud's phenomenon, is a...
Autophagic Cell Death
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...
Overview of Cell Death
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
